- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
16
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
16 companies
Alnylam Pharmaceuticals
Market Cap: US$29.8b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
ALNY
US$234.56
7D
3.7%
1Y
61.6%
Exelixis
Market Cap: US$10.1b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$36.19
7D
5.0%
1Y
60.9%
Vertex Pharmaceuticals
Market Cap: US$124.8b
A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
VRTX
US$489.10
7D
2.9%
1Y
24.3%
BeiGene
Market Cap: US$24.6b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$230.77
7D
10.8%
1Y
74.9%
Eli Lilly
Market Cap: US$659.9b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
US$839.96
7D
16.5%
1Y
12.6%
Illumina
Market Cap: US$11.6b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$71.16
7D
-0.1%
1Y
-39.0%
AbbVie
Market Cap: US$303.7b
A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
ABBV
US$172.99
7D
-0.7%
1Y
5.1%
Incyte
Market Cap: US$11.2b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$58.21
7D
5.5%
1Y
10.2%
Bristol-Myers Squibb
Market Cap: US$100.4b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
US$49.23
7D
-2.4%
1Y
1.9%
Teva Pharmaceutical Industries
Market Cap: US$15.4b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$13.65
7D
6.5%
1Y
6.8%
Gilead Sciences
Market Cap: US$130.7b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$104.53
7D
3.1%
1Y
58.0%
Natera
Market Cap: US$20.3b
A diagnostics company, provides molecular testing services worldwide.
NTRA
US$148.08
7D
3.4%
1Y
69.7%
IQVIA Holdings
Market Cap: US$26.2b
Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
IQV
US$143.91
7D
0.5%
1Y
-36.7%
Revvity
Market Cap: US$11.3b
Provides health sciences solutions, technologies, and services worldwide.
RVTY
US$91.82
7D
-1.3%
1Y
-7.6%
BioMarin Pharmaceutical
Market Cap: US$11.3b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$59.17
7D
5.1%
1Y
-34.3%
Amgen
Market Cap: US$152.0b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$277.29
7D
-1.5%
1Y
5.5%